|
Volumn 32, Issue 7, 2000, Pages 2355-2358
|
Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2
a a a a a a b c c d d |
Author keywords
[No Author keywords available]
|
Indexed keywords
GLUTAMATE AMMONIA LIGASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
ARTIFICIAL LIVER;
BIOREACTOR;
CELL LINE;
CONTROLLED STUDY;
GENE TRANSFER;
HUMAN;
HUMAN CELL;
LIVER CELL;
LIVER FAILURE;
NONHUMAN;
PRIORITY JOURNAL;
SWINE;
ANIMALS;
BIOREACTORS;
BLOOD PRESSURE;
CELL CULTURE TECHNIQUES;
EQUIPMENT DESIGN;
GLUTAMATE-AMMONIA LIGASE;
HEART RATE;
HEPATOBLASTOMA;
HEPATOCYTES;
HUMANS;
INTRACRANIAL PRESSURE;
ISCHEMIA;
LIVER;
LIVER FAILURE;
LIVER NEOPLASMS;
LIVER, ARTIFICIAL;
RECOMBINANT PROTEINS;
SWINE;
TUMOR CELLS, CULTURED;
|
EID: 0033669829
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)01697-3 Document Type: Article |
Times cited : (25)
|
References (10)
|